Nonfluent Variant Primary Progressive Aphasia (nfvPPA) research hub

Clinical Study of Neflamapimod in Patients With Primary Progressive Aphasia

This study is looking at a new drug called neflamapimod for people with a rare form of dementia called nonfluent variant primary progressive aphasia (nfvPPA). We want to see if it's safe and how it affects their language and thinking.